DSM-Firmenich AG
F:ZX61
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
DSM-Firmenich AG
F:ZX61
|
CH |
|
D
|
DEME Group NV
F:MT0
|
BE |
|
Senestech Inc
NASDAQ:SNES
|
US |
|
K
|
Kyocera Corp
XMUN:KYR
|
JP |
Intrinsic Value
Is ZX61 undervalued or overvalued?
See the intrinsic value estimate for DSM-Firmenich AG and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
ZX61 looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with ZX61’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What DSM-Firmenich Does
DSM-Firmenich makes ingredients, aromas, and nutritional products that go into everyday consumer goods. It sells fragrance ingredients and perfume compounds for personal care and home care brands, flavorings for food and drinks, and vitamins, enzymes, and other nutrition ingredients used in supplements, animal feed, and some healthcare products.
- Headquarters
- Switzerland CH
- Employees
- 26 873
- IPO date
- Apr 18, 2023
DSM-Firmenich has no economic moat
Customers have competing suppliers for flavors, fragrances and nutritional ingredients, so DSM-Firmenich must keep winning business through product quality, innovation and price. Its technical expertise and patents help individual products stand out, but do not prevent rivals from offering alternatives across its markets.
Read the full moat analysis
Revenue & Expenses Breakdown
DSM-Firmenich AG
Earnings Waterfall
DSM-Firmenich AG
The intrinsic value for DSM-Firmenich AG (ZX61) under the Base Case is hidden EUR.
Compared with the current market price of 9.65 EUR, the stock appears hidden.